Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 12, 2012

FDA Okay for Respiratory Virus Test Panel

  • GenMark Diagnostics received 510(k) clearance for its eSensor® Respiratory Virus Panel, for use on the XT-8 system. The assay is designed to simultaneously detect and differentiate 14 viruses and viral subtypes from patients with influenza-like symptoms, including rhinovirus, enterovirus, and clinically relevant adenovirus infections. “The FDA clearance of our eSensor Respiratory Virus Panel test further demonstrates the capability of our uniquely differentiated electronic detection technology,“ comments Hany Massarany, GenMark president and CEO.

    GenMark’s e-Sensor XT-8 system is designed to support a range of molecular diagnostic tests carried out in self-contained, disposable test cartridges. In addition to the Respiratory Virus Panel, three additional tests have been cleared by FDA: Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test, and Thrombophilia Risk Tests. Other tests, including HCV genotyping and 2C19, are in development.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »